In the BioHarmony Drug Report Database

"Preview" Icon

Nizatidine

Axid, Axid Ar (nizatidine) is a small molecule pharmaceutical. Nizatidine was first approved as Axid on 1988-04-12. It is used to treat duodenal ulcer, dyspepsia, gastroesophageal reflux, heartburn, and helicobacter infections amongst others in the USA. Nizatidine’s patent is valid until 2022-07-17 (FDA).

 

Trade Name

 

Axid, Axid Ar
 

Common Name

 

nizatidine
 

ChEMBL ID

 

CHEMBL3183075
 

Indication

 

duodenal ulcer, dyspepsia, gastroesophageal reflux, heartburn, helicobacter infections, peptic esophagitis, stomach ulcer, urticaria, zollinger-ellison syndrome
 

Drug Class

 

H2-receptor antagonists (cimetidine type)

Image (chem structure or protein)

Nizatidine structure rendering